These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 8677252)

  • 1. The impact of genetic developments on breast cancer.
    Favors AC
    Med Sect Proc; 1995; ():49-59. PubMed ID: 8677252
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hereditary breast cancer: genetic bases and clinical features].
    Brunet J; Alonso MC; Ojeda B
    Med Clin (Barc); 1994 Nov; 103(16):623-7. PubMed ID: 7996921
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic susceptibility to breast and ovarian cancer.
    Skolnick MH; Frank T; Shattuck-Eidens D; Tavtigian S
    Pathol Biol (Paris); 1997 Mar; 45(3):245-9. PubMed ID: 9296070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic testings for cancer: the surgeon's critical role. Familial breast cancer.
    Weber BL
    J Am Coll Surg; 1999 Jan; 188(1):79-86. PubMed ID: 9915248
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hereditary breast and ovarian cancer syndrome].
    Plevová P; Novotný J; Petráková K; Palácová M; Kalábová R; Schneiderová M; Foretová L
    Klin Onkol; 2009; 22 Suppl():S8-11. PubMed ID: 19764385
    [No Abstract]   [Full Text] [Related]  

  • 6. [Inherited breast and ovarian cancers].
    Gerdes AM; Ejlertsen B
    Ugeskr Laeger; 2006 Jun; 168(24):2367-9. PubMed ID: 16822422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Allelic loss on chromosome 11q13 in male breast cancer].
    Sanz Ortega J
    An R Acad Nac Med (Madr); 1995; 112(4):669-77. PubMed ID: 8678213
    [No Abstract]   [Full Text] [Related]  

  • 8. Popularity of breast cancer program leads to referral protocols in BC.
    Kent H
    CMAJ; 1998 Oct; 159(7):832-3. PubMed ID: 9805033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics and the multidisciplinary breast center.
    Peters JA; Rubinstein WS
    Surg Oncol Clin N Am; 2000 Apr; 9(2):367-96. PubMed ID: 10757850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hereditary cancer of the breast and ovary].
    Díez Gibert O; Machuca Cordano I; Navarro MA
    Med Clin (Barc); 1998 Feb; 110(5):199. PubMed ID: 9547728
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk assessment and presymptomatic molecular diagnosis in hereditary breast cancer.
    Merajver SD; Petty EM
    Clin Lab Med; 1996 Mar; 16(1):139-67. PubMed ID: 8867588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Family history of breast and ovarian cancer among breast-cancer patients in the Connecticut Tumor Registry.
    Polednak AP; Flannery JT
    Conn Med; 1996 Feb; 60(2):67-73. PubMed ID: 8820629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. I1307K APC variant in non-Ashkenazi Jewish women affected with breast cancer.
    Nathanson KL; Antin-Ozerkis D; Couch FJ; Weber BL
    Am J Med Genet; 1999 Jul; 85(2):189-90. PubMed ID: 10406676
    [No Abstract]   [Full Text] [Related]  

  • 14. Screening of male breast cancer and of breast-ovarian cancer families for BRCA2 mutations using large bifluorescent amplicons.
    Pages S; Caux V; Stoppa-Lyonnet D; Tosi M
    Br J Cancer; 2001 Feb; 84(4):482-8. PubMed ID: 11207042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of germline BRCA1 and BRCA2 genetic alterations in Greek breast cancer moderate-risk and low-risk individuals--correlation with clinicopathological data.
    Kataki A; Gomatos I; Pararas N; Armakolas A; Panousopoulos D; Karantzikos G; Voros D; Zografos G; Markopoulos C; Leandros E; Konstadoulakis M
    Clin Genet; 2005 Apr; 67(4):322-9. PubMed ID: 15733268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of the BRCA1 del (exons 9-12) mutation in breast/ovarian cancer families outside of Mexican Hispanics.
    Torres D; Rashid MU; ; Seidel-Renkert A; Weitzel JN; Briceno I; Hamann U
    Breast Cancer Res Treat; 2009 Oct; 117(3):679-81. PubMed ID: 19333752
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families.
    Osorio A; Barroso A; Martínez B; Cebrián A; San Román JM; Lobo F; Robledo M; Benítez J
    Br J Cancer; 2000 Apr; 82(7):1266-70. PubMed ID: 10755399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary breast cancer: a review.
    Arver B; Du Q; Chen J; Luo L; Lindblom A
    Semin Cancer Biol; 2000 Aug; 10(4):271-88. PubMed ID: 10966850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
    Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
    Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations.
    Fackenthal JD; Olopade OI
    Nat Rev Cancer; 2007 Dec; 7(12):937-48. PubMed ID: 18034184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.